Cargando…
Video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non‐small cell lung cancer patients
BACKGROUND: The majority of previous studies of the clinical outcome of video‐assisted thoracoscopic surgery (VATS) versus open lobectomy for pathological N2 non‐small cell lung cancer (pN2 NSCLC) have been single‐center experiences with small patient numbers. The aim of this study was therefore to...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779187/ https://www.ncbi.nlm.nih.gov/pubmed/33205914 http://dx.doi.org/10.1111/1759-7714.13680 |
_version_ | 1783631283813875712 |
---|---|
author | Zhao, Jinbo Li, Weimiao Wang, Meng Liu, Lunxu Fu, Xiangning Li, Yin Xu, Lin Liu, Yang Zhao, Heng Hu, Jian Liu, Deruo Shen, Jianfei Yang, Haiying Li, Xiaofei |
author_facet | Zhao, Jinbo Li, Weimiao Wang, Meng Liu, Lunxu Fu, Xiangning Li, Yin Xu, Lin Liu, Yang Zhao, Heng Hu, Jian Liu, Deruo Shen, Jianfei Yang, Haiying Li, Xiaofei |
author_sort | Zhao, Jinbo |
collection | PubMed |
description | BACKGROUND: The majority of previous studies of the clinical outcome of video‐assisted thoracoscopic surgery (VATS) versus open lobectomy for pathological N2 non‐small cell lung cancer (pN2 NSCLC) have been single‐center experiences with small patient numbers. The aim of this study was therefore to investigate these procedures but in a large cohort of Chinese patients with pathological N2 NSCLC in real‐world conditions. METHODS: Patients who underwent lobectomy for pN2 NSCLC by either VATS or thoracotomy were retrospectively reviewed from 10 tertiary hospitals between January 2014 and September 2017. Perioperative outcomes and overall survival of the patients were analyzed. Cox regression analysis was performed to identify potential prognostic factors. Propensity‐score analysis was performed to reduce cofounding biases and compare the clinical outcomes between both groups. RESULTS: Among 2144 pN2 NSCLC, 1244 patients were managed by VATS and 900 by open procedure. A total of 305 (24.5%) and 344 patients died during VATS and the thoracotomy group during a median follow‐up of 16.7 and 15.6 months, respectively. VATS lobectomy patients had better overall survival when compared with those undergoing the open procedure (P < 0.0001). Multivariate COX regression analysis showed VATS lobectomy independently favored overall survival (HR = 0.75, 95% CI: 0.621–0.896, P = 0.0017). Better perioperative outcomes, including less blood loss, shorter drainage time and hospital stay, were also observed in patients undergoing VATS lobectomy (P < 0.05). After propensity‐score matching, 169 patients in each group were analyzed, and no survival difference were found between the two groups. Less blood loss was observed in the VATS group, but there was a longer operation time. CONCLUSIONS: VATS lobectomy might be a feasible alternative to conventional open surgery for resectable pN2 NSCLC. KEY POINTS: Significant findings of the study: VATS lobectomy has comparative OS in pN2 NSCLC versus open procedure in resectable patients. What this study adds: VATS lobectomy might be feasible for pN2 NSCLC. |
format | Online Article Text |
id | pubmed-7779187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-77791872021-01-08 Video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non‐small cell lung cancer patients Zhao, Jinbo Li, Weimiao Wang, Meng Liu, Lunxu Fu, Xiangning Li, Yin Xu, Lin Liu, Yang Zhao, Heng Hu, Jian Liu, Deruo Shen, Jianfei Yang, Haiying Li, Xiaofei Thorac Cancer Original Articles BACKGROUND: The majority of previous studies of the clinical outcome of video‐assisted thoracoscopic surgery (VATS) versus open lobectomy for pathological N2 non‐small cell lung cancer (pN2 NSCLC) have been single‐center experiences with small patient numbers. The aim of this study was therefore to investigate these procedures but in a large cohort of Chinese patients with pathological N2 NSCLC in real‐world conditions. METHODS: Patients who underwent lobectomy for pN2 NSCLC by either VATS or thoracotomy were retrospectively reviewed from 10 tertiary hospitals between January 2014 and September 2017. Perioperative outcomes and overall survival of the patients were analyzed. Cox regression analysis was performed to identify potential prognostic factors. Propensity‐score analysis was performed to reduce cofounding biases and compare the clinical outcomes between both groups. RESULTS: Among 2144 pN2 NSCLC, 1244 patients were managed by VATS and 900 by open procedure. A total of 305 (24.5%) and 344 patients died during VATS and the thoracotomy group during a median follow‐up of 16.7 and 15.6 months, respectively. VATS lobectomy patients had better overall survival when compared with those undergoing the open procedure (P < 0.0001). Multivariate COX regression analysis showed VATS lobectomy independently favored overall survival (HR = 0.75, 95% CI: 0.621–0.896, P = 0.0017). Better perioperative outcomes, including less blood loss, shorter drainage time and hospital stay, were also observed in patients undergoing VATS lobectomy (P < 0.05). After propensity‐score matching, 169 patients in each group were analyzed, and no survival difference were found between the two groups. Less blood loss was observed in the VATS group, but there was a longer operation time. CONCLUSIONS: VATS lobectomy might be a feasible alternative to conventional open surgery for resectable pN2 NSCLC. KEY POINTS: Significant findings of the study: VATS lobectomy has comparative OS in pN2 NSCLC versus open procedure in resectable patients. What this study adds: VATS lobectomy might be feasible for pN2 NSCLC. John Wiley & Sons Australia, Ltd 2020-11-18 2021-01 /pmc/articles/PMC7779187/ /pubmed/33205914 http://dx.doi.org/10.1111/1759-7714.13680 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Zhao, Jinbo Li, Weimiao Wang, Meng Liu, Lunxu Fu, Xiangning Li, Yin Xu, Lin Liu, Yang Zhao, Heng Hu, Jian Liu, Deruo Shen, Jianfei Yang, Haiying Li, Xiaofei Video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non‐small cell lung cancer patients |
title | Video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non‐small cell lung cancer patients |
title_full | Video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non‐small cell lung cancer patients |
title_fullStr | Video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non‐small cell lung cancer patients |
title_full_unstemmed | Video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non‐small cell lung cancer patients |
title_short | Video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non‐small cell lung cancer patients |
title_sort | video‐assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological n2 non‐small cell lung cancer patients |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779187/ https://www.ncbi.nlm.nih.gov/pubmed/33205914 http://dx.doi.org/10.1111/1759-7714.13680 |
work_keys_str_mv | AT zhaojinbo videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT liweimiao videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT wangmeng videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT liulunxu videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT fuxiangning videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT liyin videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT xulin videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT liuyang videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT zhaoheng videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT hujian videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT liuderuo videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT shenjianfei videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT yanghaiying videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients AT lixiaofei videoassistedthoracoscopicsurgerylobectomymightbeafeasiblealternativeforsurgicallyresectablepathologicaln2nonsmallcelllungcancerpatients |